Given that our scRNA-seq study was conducted on the Brca1-deficiency mouse breast cancer model to elucidate the microenvironmental impact of obesity on breast cancer development, our findings may form the basis for the future development of obesity-related therapeutic and preventive interventions. This evidence concerns the gene BRCA1 and obesity due to melanocortin 4 receptor deficiency.